Table 2.
Significant KEGG pathways obtained from DAVID (P < 0.005).
| ID | Description | ID | Description |
|---|---|---|---|
| hsa00020 | Citrate cycle (TCA cycle) | hsa04966 | Collecting duct acid secretion |
| hsa00190 | Oxidative phosphorylation | hsa05010 | Alzheimer's disease |
| hsa00260 | Glycine, serine and threonine metabolism | hsa05012 | Parkinson's disease |
| hsa00620 | Pyruvate metabolism | hsa05014 | Amyotrophic lateral sclerosis |
| hsa01200 | Carbon metabolism | hsa05016 | Huntington disease |
| hsa01210 | 2-Oxocarboxylic acid metabolism | hsa05017 | Spinocerebellar ataxia |
| hsa01230 | Biosynthesis of amino acids | hsa05020 | Prion disease |
| hsa01522 | Endocrine resistance | hsa05022 | Pathways of neurodegeneration - multiple diseases |
| hsa03050 | Proteasome | hsa05032 | Morphine addiction |
| hsa04010 | MAPK signaling pathway | hsa05033 | Nicotine addiction |
| hsa04070 | Phosphatidylinositol signaling system | hsa05110 | Vibrio cholerae infection |
| hsa04071 | Sphingolipid signaling pathway | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection |
| hsa04110 | Cell cycle | hsa05131 | Shigellosis |
| hsa04120 | Ubiquitin mediated proteolysis | hsa05132 | Salmonella infection |
| hsa04137 | Mitophagy - animal | hsa05140 | Leishmaniasis |
| hsa04140 | Autophagy - animal | hsa05145 | Toxoplasmosis |
| hsa04144 | Endocytosis | hsa05152 | Tuberculosis |
| hsa04145 | Phagosome | hsa05163 | Human cytomegalovirus infection |
| hsa04152 | AMPK signaling pathway | hsa05167 | Kaposi sarcoma-associated herpesvirus infection |
| hsa04211 | Longevity regulating pathway | hsa05169 | Epstein-Barr virus infection |
| hsa04218 | Cellular senescence | hsa05202 | Transcriptional misregulation in cancer |
| hsa04260 | Cardiac muscle contraction | hsa05205 | Proteoglycans in cancer |
| hsa04360 | Axon guidance | hsa05212 | Pancreatic cancer |
| hsa04625 | C-type lectin receptor signaling pathway | hsa05214 | Glioma |
| hsa04666 | Fc gamma R-mediated phagocytosis | hsa05215 | Prostate cancer |
| hsa04721 | Synaptic vesicle cycle | hsa05219 | Bladder cancer |
| hsa04722 | Neurotrophin signaling pathway | hsa05220 | Chronic myeloid leukemia |
| hsa04723 | Retrograde endocannabinoid signaling | hsa05223 | Non-small cell lung cancer |
| hsa04920 | Adipocytokine signaling pathway | hsa05225 | Hepatocellular carcinoma |
| hsa04932 | Non-alcoholic fatty liver disease | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer |
| hsa04961 | Endocrine and other factor-regulated calcium reabsorption |